BeStock  

Accenture ACN

US equityMarket cap rank #127Information Technology Services
$260.50 −$4.66 (-1.76%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $260.03 -0.18%
Open$258.53
Prev close$265.16
Day range$255.41 – $261.22
Volume4.26M
Market cap$155.26B
P/E (TTM)19.2
Dividend yield2.50%

Dividends

Dividend yield (TTM)2.50%
Last dividend$1.71Ex-date 13 Oct 2026
Next-to-last$1.63
Payments on file40

Repeating the last declared payment 4 times a year (its usual pace) works out to a forward annual dividend of $6.84, a 2.63% forward yield at today’s price.

Dividends paid per share, by year

3.2820203.6120214.0320225.7720235.3520246.072025

Across the full calendar years shown, the annual payout grew by roughly 13.1% a year.

The payout has held steady or grown for 2 straight full years on file.

Ex-datePay dateAmount
13 Oct 2026 13 Nov 2026 $1.71
9 Jul 2026 14 Aug 2026 $1.63
9 Apr 2026 15 May 2026 $1.63
13 Jan 2026 13 Feb 2026 $1.63
10 Oct 2025 14 Nov 2025 $1.63
10 Jul 2025 15 Aug 2025 $1.48
10 Apr 2025 15 May 2025 $1.48
16 Jan 2025 14 Feb 2025 $1.48
10 Oct 2024 15 Nov 2024 $1.48
11 Jul 2024 15 Aug 2024 $1.29
10 Apr 2024 15 May 2024 $1.29
17 Jan 2024 15 Feb 2024 $1.29
11 Oct 2023 15 Nov 2023 $1.29
12 Jul 2023 15 Aug 2023 $1.12
12 Apr 2023 15 May 2023 $1.12
11 Jan 2023 15 Feb 2023 $1.12
9 Jan 2023 15 Feb 2023 $1.12
12 Oct 2022 15 Nov 2022 $1.12
13 Jul 2022 15 Aug 2022 $0.97
13 Apr 2022 13 May 2022 $0.97
12 Jan 2022 15 Feb 2022 $0.97
13 Oct 2021 15 Nov 2021 $0.97
14 Jul 2021 13 Aug 2021 $0.88
14 Apr 2021 14 May 2021 $0.88
13 Jan 2021 12 Feb 2021 $0.88
9 Oct 2020 13 Nov 2020 $0.88
15 Jul 2020 14 Aug 2020 $0.80
15 Apr 2020 15 May 2020 $0.80
15 Jan 2020 14 Feb 2020 $0.80
16 Oct 2019 15 Nov 2019 $0.80
10 Apr 2019 15 May 2019 $1.46
17 Oct 2018 15 Nov 2018 $1.46
11 Apr 2018 15 May 2018 $1.33
18 Oct 2017 15 Nov 2017 $1.33
11 Apr 2017 15 May 2017 $1.21
19 Oct 2016 15 Nov 2016 $1.21
13 Apr 2016 13 May 2016 $1.10
14 Oct 2015 13 Nov 2015 $1.10
8 Apr 2015 15 May 2015 $1.02
15 Oct 2014 17 Nov 2014 $1.02

Discussion

No comments yet — be the first to weigh in on ACN.

Sign in to join the discussion.

Scroll to Top